Genetic alterations, RNA expression profiling and DNA methylation of HMGB1 in malignancies악성 종양에서 HMGB1의 유전적 변경, RNA 발현 프로파일링 및 DNA 메틸화Article Published on 2022-08-012022-09-11 Journal: Journal of Cellular and Molecular Medicine [Category] 바이오마커, [키워드] alterations analysed Analysis B-cell lymphoma bioinformatics Biomarker cancers COVID-19 Covid-19 biomarker diffuse large B-cell lymphoma DNA methylation evaluate expression Genetic Genetic variation HMGB1 human cancer human cancers human diseases lymphoid malignancy neoplasm overexpressed pan-cancer. pancreatic positive correlation Prognosis reported RNA expression survival therapeutic target thymoma tissues Tumours [DOI] 10.1111/jcmm.17454 PMC 바로가기 [Article Type] Article
Effects of Casirivimab/Imdevimab Monoclonal Antibody Treatment among Vaccinated Patients Infected by SARS-CoV-2 Delta VariantSARS-CoV-2 Delta 변이에 감염된 백신 접종 환자에서 Casirivimab/Imdevimab 단일클론항체 치료 효과Article Published on 2022-03-212022-09-11 Journal: Viruses [Category] SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome Analysis B.1.617.2 Casirivimab casirivimab/imdevimab Chest Chest computed tomography clinical clinical evolution clinical manifestations Clinical presentations cocktail Computed tomography coronavirus coronavirus 2 Delta delta variant Disease progression early stage early stages Effect effective Efficacy evaluated Evolution FIVE Hospitalized Imdevimab Infection mAb mAbs monoclonal antibodies monoclonal antibody monoclonal antibody treatment Nasopharyngeal swab nasopharyngeal swabs Next-generation sequencing NGS outcomes Patient patients performed prevent disease progression real-time RT-PCR Regression respiratory Respiratory failure Safe SARS-CoV-2 Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 submitted Symptom Symptoms thymoma Treatment Vaccine variant variants variants of concern variants of concern. Viral viral load reduction [DOI] 10.3390/v14030650 PMC 바로가기 [Article Type] Article
Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity다양한 선천성 면역 오류가 있는 개인의 SARS-CoV-2 백신에 대한 항체 반응Article Published on 2021-11-012022-09-11 Journal: The Journal of Allergy and Clinical Immunology [Category] MERS, SARS, 진단, 치료법, [키워드] adverse event adverse events affected age anti-S anti-S IgG anti-S IgG levels antibody Antibody Response Antibody titer Antibody titers Autoimmune B cells B-cell baseline candidiasis Care CD19 CD3 Cohort cohort of patient completion controls counseling COVID-19 COVID-19 vaccine Diagnosis dose evaluate Genetic Health Health care immune immune suppressants Immunity immunization immunization schedule immunized immunogenicity immunomodulators immunosuppressive drug immunosuppressive drugs Inborn errors inborn errors of immunity. individual information Jak jak inhibitors janssen Johnson & Johnson less luciferase Luciferase immunoprecipitation system median medical records mRNA vaccine Patient patients plasma rate of seroconversion reported rituximab Safe SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 vaccination second dose Seroconversion single dose subsequent T cells the SARS-CoV-2 therapy These data thymoma Treatment Vaccinating Vaccine was collected were measured [DOI] 10.1016/j.jaci.2021.08.016 PMC 바로가기 [Article Type] Article